BCL2L12 and glioblastoma: More recently, comprehensive oncogenomic and tissue microarray analyses validated robust amplification (nonfocal gain of chromosome 19q13) and overexpression of the noncanonical Bcl-2 family protein, Bcl-2-Like 12 (Bcl2L12) in primary GBM tumor specimens.